So the NADIM II trial is a Phase II trial in which patients are randomized to receive either nivolumab plus chemotherapy or chemotherapy alone. And the aim is to demonstrate or validate our results that were found in NADIM trial, the previous trial and CheckMate 816 trial. So the primary endpoint was pathological complete response and here, Professor Mariano Provencio will be presenting data on PFS and overall survival...
So the NADIM II trial is a Phase II trial in which patients are randomized to receive either nivolumab plus chemotherapy or chemotherapy alone. And the aim is to demonstrate or validate our results that were found in NADIM trial, the previous trial and CheckMate 816 trial. So the primary endpoint was pathological complete response and here, Professor Mariano Provencio will be presenting data on PFS and overall survival.